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Abstract Patients with diabetes mellitus show in-
creased risk of infectious disease as well as dis-
turbances in innate immunity. In critical care settings,
hyperglycemia is associated with increased risk of
sepsis. It is unclear whether elevated glucose concen-
trations and innate immunity are associated in a non-
clinical setting. We aimed to assess the association
between glucose concentrations and innate immune
response in the oldest old, who are at increased risk of
both disturbed glucose metabolism as well as infec-
tious disease. This study was part of the Leiden 85-
plus Study. In 562 subjects aged 85 years old of the
general population, venous blood samples were taken
for measurement of morning glucose, C-reactive
protein (CRP) and glycated hemoglobin (HbA1c).
The innate immune response was assessed by
performing ex vivo whole blood lipopolysaccharide
(LPS) stimulation for production capacity of tumor
necrosis factor alpha (TNF-α), interleukin 6 (IL-6),
interleukin 1-beta (IL1-β), interleukin 10 (IL-10) and
interleukin 1 receptor antagonist (IL-1Ra). Using
linear regression analysis, cross-sectional analysis
between glucose and cytokine production capacity
was performed. We found a significant negative
association between glucose concentrations, but not
HbA1c, and cytokine response capacity in four out of
five measured cytokines (all p<0.05). Both glucose
and HbA1c were positively associated with circulat-
ing levels of CRP. Higher glucose concentrations in
non-diabetic elderly are associated with lower innate
immune response. As elderly show increased vulner-
ability for disturbances in glucose metabolism as well
as infectious disease, this relation could be of clinical
significance.
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Introduction
Patients with diabetes mellitus have a higher vulner-
ability for infectious diseases, which contributes to
increased hospitalization and mortality (Shah and Hux
2003). It has been hypothesized that elevated glucose
concentrations negatively influence cytokine produc-
tion and neutrophil function (Andreasen et al. 2010;
Delamaire et al. 1997). In vitro studies testing the
effect of different glucose concentrations on innate
immunity have yielded conflicting results (reviewed
by Geerlings and Hoepelman 1999). In healthy young
subjects, induction of hyperglycemia and lipopoly-
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saccharide (LPS) stimulation in vivo did not attenuate
the cytokine response (Krogh-Madsen et al. 2004). In
the critical care setting, detrimental effects of hyper-
glycemia have been shown in non-diabetic patients,
where stress-induced hyperglycemia is related to
higher risk of sepsis and increased morbidity and
mortality (Van den Berghe et al. 2001)
In the oldest old both infectious disease and
disturbances of glucose homeostasis are highly
prevalent. In the present study we tested the relation-
ship between innate immunity and glucose concen-
trations in non-acutely diseased community-dwelling
85-year-olds without diabetes mellitus.
Methods
The Leiden 85-plus Study is a prospective, observa-
tional, population-based follow-up study of all inhab-
itants aged 85 years in Leiden, The Netherlands.
Subjects were enrolled between 1997 and 1999. All
participants were aged 85 years. There were no
exclusion criteria. Of the 705 eligible subjects, 599
subjects were willing to participate (87%). At base-
line, non-fasted venous blood samples were obtained
in the morning (before 11:00 AM) of all participants.
Ex vivo whole blood LPS stimulation was performed in
562 subjects. Levels of tumor necrosis factor alpha
(TNF-α), interleukin 6 (IL-6), interleukin 1-beta
(IL1-β), interleukin 10 (IL-10) and interleukin 1
receptor antagonist (IL-1Ra) were determined 24 h
after incubation with LPS, as more extensively
described earlier (Van der Linden et al. 1998).
Non-fasted plasma glucose concentrations, glycated
hemoglobin (HbA1c) and C-reactive protein (CRP)
levels were measured in 559 subjects. Subjects with
known diabetes (n=52) or hyperglycemia (non-fasted
glucose >11 mmol/l, n=39) were excluded from
analysis. Analyses were done using linear regression
with adjustment for gender using SPSS version 16.0.
Results
Figure 1 shows the relation between quartiles of
glucose and cytokine levels in response to LPS-
stimulation in 468 participants. After adjustment for
gender, concentrations of non-fasted glucose correlated
negatively with TNF-α, IL-6, IL-1β, and IL-10 (all p
for trend <0.05), but not with IL-1Ra (p for trend=
0.73). Additionally excluding the subjects with gly-
cated hemoglobin >6.5% (n=20) did not alter results
Fig. 1 Cytokine production after LPS-stimulation ex vivo by glucose concentration (n=468). Cytokine data represent geometric
means ±95% confidence intervals, after linear regression with adjustment for gender
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(data not shown). Glucose concentrations were posi-
tively associated with CRP (p for trend=0.02).
To assess whether the association between innate
immunity and glucose concentrations was affected by
acute or long-term regulation of glucose metabolism,
we repeated the analyses of stimulated cytokine levels
dependent on HbA1c. No consistent linear association
was found between HbA1c and cytokines levels in
response to LPS-stimulation (data not shown). HbA1c
did correlate positively with CRP levels (p=0.001)
Discussion
We found a strong negative association between non-
fasted glucose concentrations, but not HbA1c levels,
and cytokine production upon LPS stimulation ex
vivo in a community-dwelling, non-diabetic popula-
tion of the oldest old. Both non-fasted glucose
concentrations and HbA1c showed a positive corre-
lation with CRP levels.
The observed relationship between non-fasted glucose
and cytokine production capacity in non-diabetic subjects
suggests that alterations in glucose metabolism, even in
non-diabetics, may attenuate innate immune response.
The lack of association between HbA1c and cytokine
levels suggests that this effect might be driven by
temporarily increases of glucose rather than chronic
elevations. Earlier, hyperglycemic fluctuations, rather
than continuous hyperglycemia, have been associated
with negative outcome in a non-diabetic population
cohort (Barr et al. 2009).
The relationship between higher glucose concen-
trations and low cytokine response could be of
clinical significance. A low cytokine response has
been independently associated with morbidity and
mortality in our study population of the oldest old
(van den Biggelaar et al. 2004). Furthermore, a low
cytokine response has been associated with detri-
mental outcome in patients with sepsis at the
intensive care unit (Muller Kobold et al. 2000;
Westendorp et al. 1997). Also in this acutely ill
patient cohort, innate immune response related
inversely to levels of inflammation, such as CRP
(Tschaikowsky et al. 2002).
A limitation of this study is that we did not
measure insulin sensitivity. Insulin sensitivity has
been associated with higher circulating inflammatory
markers and is a prognostic factor for outcome in
critically ill patients with myocardial infarction
(Lazzeri et al. 2011; Zuliani et al. 2010). We were
therefore not able to assess which mechanism of
glucose metabolism is associated with innate
immune function. Furthermore, as glucose concentra-
tions were assessed at one time point only, we could
also not assess glycemic variability accurately. Further
studies with sensitive tools, such as continuous glucose
monitoring systems, could better clarify this issue.
Importantly, our results were found in a non-
diabetic population, suggesting that the blunted
cytokine response is not due to specific factors related
to diabetes mellitus, such as use of anti-diabetic
medication, or other pathophysiological changes due
to the disease, but suggest a direct relationship
between glucose concentration and innate immune
response. This association might be of clinical
importance, as also in apparently healthy older
individuals, disturbances in glucose and insulin
metabolism are found such as impaired beta-cell
function and decreased insulin action (Basu et al.
2003; Chang et al. 2006). Moreover, the glycemic
response to stress might be increased with aging,
which could further aggravate glycemic disturbances
in clinical settings (Lazzeri et al. 2010; Odio and
Brodish 1988).
Further studies in vivo including non-diabetic
subjects are warranted to identify the mechanism
behind the association between glucose concentrations
and innate immune response and to investigate whether
results can be extended to younger populations.
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